These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28893955

  • 1. NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.
    Sharma N, Trinidad CV, Trembath AP, Markiewicz MA.
    J Immunol; 2017 Oct 15; 199(8):2865-2872. PubMed ID: 28893955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
    Hu L, Cao D, Li Y, He Y, Guo K.
    Cancer Biol Ther; 2012 May 15; 13(7):516-26. PubMed ID: 22406996
    [Abstract] [Full Text] [Related]

  • 4. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
    Brennan K, McSharry BP, Keating S, Petrasca A, O'Reilly VP, Keane J, Doherty DG, Gardiner CM.
    Hum Immunol; 2016 Oct 15; 77(10):876-885. PubMed ID: 27349945
    [Abstract] [Full Text] [Related]

  • 5. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
    FASEB J; 2013 Jun 15; 27(6):2440-50. PubMed ID: 23395909
    [Abstract] [Full Text] [Related]

  • 6. Natural Killer Cells Reprogram Myeloid-Derived Suppressor Cells to Induce TNF-α Release via NKG2D-Ligand Interaction after Cryo-Thermal Therapy.
    You J, Wang S, Zhu Y, Zhang Z, Wang J, Lou Y, Yao Y, Hao Y, Liu P.
    Int J Mol Sci; 2024 May 09; 25(10):. PubMed ID: 38791188
    [Abstract] [Full Text] [Related]

  • 7. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S.
    BMC Immunol; 2012 Feb 08; 13():7. PubMed ID: 22316211
    [Abstract] [Full Text] [Related]

  • 8. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L, Ashiru O, Agüera-González S, Reyburn HT, Valés-Gómez M.
    J Cell Sci; 2011 Feb 01; 124(Pt 3):321-7. PubMed ID: 21224393
    [Abstract] [Full Text] [Related]

  • 9. Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors.
    Poggi A, Prevosto C, Massaro AM, Negrini S, Urbani S, Pierri I, Saccardi R, Gobbi M, Zocchi MR.
    J Immunol; 2005 Nov 15; 175(10):6352-60. PubMed ID: 16272287
    [Abstract] [Full Text] [Related]

  • 10. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.
    J Leukoc Biol; 2005 Aug 15; 78(2):359-71. PubMed ID: 15937142
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.
    Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS, Hwang YK, Lee JK.
    Cell Immunol; 2012 Apr 01; 276(1-2):122-7. PubMed ID: 22613008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natural killer cell-mediated shedding of ULBP2.
    Wang R, Sun PD.
    PLoS One; 2014 Apr 01; 9(3):e91133. PubMed ID: 24614922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
    Dejaco C, Duftner C, Al-Massad J, Wagner AD, Park JK, Fessler J, Aigelsreiter A, Hafner F, Vega S, Sterlacci W, Grubeck-Loebenstein B, Tzankov A, Ness T, Boiardi L, Salvarani C, Schirmer M.
    Ann Rheum Dis; 2013 Nov 01; 72(11):1852-9. PubMed ID: 23417963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner.
    Bálint Š, Lopes FB, Davis DM.
    Sci Signal; 2018 Apr 10; 11(525):. PubMed ID: 29636390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.